Carlyle makes a significant investment in Resonetics

Carlyle-managed funds have acquired a significant interest in medical device contract manufacturer Resonetics.

Today’s announcement did not include the investment size, but the deal values Nashua, New Hampshire–based Resonetics at roughly  $2.25 billion.

Carlyle joins existing investor GTCR as a meaningful shareholder in the company.

Resonetics focuses on producing highly technical components for medical device applications, providing services from design and development to high-volume manufacturing.

“Our business has advanced significantly over the past four years, expanding on our scale and capabilities and becoming an increasingly valuable partner to our customers, and we look forward to keeping the momentum going,” Resonetics CEO Tom Burns said in a news release.

Steve Wise, a Carlyle managing director and head of global healthcare, said Carlyle’s global network will open up new avenues of organic opportunities for Resonetic…

Read more
  • 0

Private equity firms making majority investment in Medline

Medline Industries will stay a privately-held, family-run medtech giant after a majority investment from private equity firms.

Blackstone, Carlyle and Hellman & Friedman are making the investment in Medline, which media reports peg at $34 billion.

Medline will continue to be family-led by CEO Charlie Mills, President Andy Mills and COO Jim Abrams will continue to lead the company — as they have since 1997 — and the senior management team will remain. The Mills family will also remain the largest single shareholder.

Medline plans to use the influx of cash to expand its product offerings, accelerate international expansion and continue to make new infrastructure investments to strengthen its global supply chain. Medline saw $17.5 billion in revenue in 2020.

“Making healthcare run better has been our focus for decades. This investment from some of the world’s most experienced and successful private investment firms will enable us to accelerate th…

Read more
  • 0